Genetics for dermatologists. Part 2: Clinical evaluation, sequencing technologies and interpretation
- PMID: 40357951
- DOI: 10.25259/IJDVL_500_2024
Genetics for dermatologists. Part 2: Clinical evaluation, sequencing technologies and interpretation
Abstract
Genomic sequencing technologies have revolutionised the diagnostic approach to genodermatoses, facilitating precise diagnosis, offering unparalleled insights into pathogenesis, and guiding personalised treatment strategies. In this article, we provide an outline for clinical evaluation, how to choose the most suitable genetic test for different dermatological presentations and examine indications for single-gene tests, gene panels, whole exome, and whole genome sequencing. We then delve into sequencing technologies, including next-generation sequencing (NGS) and its various platforms, detailing their strengths, limitations, and clinical applications. By understanding these technologies, clinicians will be better equipped to interpret test results accurately and collaborate with genetic counsellors and laboratory experts effectively.
Keywords: Genodermatoses; next-generation sequencing; sanger sequencing; variant classification.
References
-
- Tantcheva-PoórI,OjiV,HasC,.A multistep approach to the diagnosis of rare genodermatoses.J Dtsch Dermatol Ges.2016; 14:969-86
-
- O’Donnell-LuriaAH,MillerDT,.A Clinician’s perspective on clinical exome sequencing.Hum Genet.2016; 135:643-54
-
- UittoJ,SaeidianAH,YoussefianL,VahidnezhadH,.Interpretation of genomic sequence variants in heritable skin diseases: A primer for clinicians.J Am Acad Dermatol.2023; 89:569-76
-
- StoranER,IrvineAD,.Access to genetic diagnostics for genodermatoses: Who should get tested? why? who pays?.Pediatr Dermatol.2017; 34:105-8
-
- SalikD,RichertB,SmitsG,.Clinical and molecular diagnosis of genodermatoses: Review and perspectives.J Eur Acad Dermatol Venereol.2023; 37:488-500
Publication types
LinkOut - more resources
Full Text Sources
